{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT05016804",
      "OrgStudyIdInfo": {
        "OrgStudyId": "SC-10-ATG-12-04"
      },
      "Organization": {
        "OrgFullName": "The Foundation for Orthopaedics and Regenerative Medicine",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis",
      "OfficialTitle": "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Systemic Sclerosis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "February 2022",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "November 2025",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "November 2025",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "August 17, 2021",
      "StudyFirstSubmitQCDate": "August 17, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 23, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "January 4, 2022",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 5, 2022",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "The Foundation for Orthopaedics and Regenerative Medicine",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "Yes",
      "IsFDARegulatedDevice": "No",
      "IsUSExport": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Systemic Sclerosis",
      "DetailedDescription": "Studies have shown that stem cell treatment is safe and efficacious for the treatment of Systemic Sclerosis. Patients with Systemic Sclerosis will receive a single intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells. The total dose will be 100 million cells. Patients will be evaluated within one month pre treatment and at 1, 6, 12, 24, 36, and 48 months post treatment for safety and efficacy."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Systemic Sclerosis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Systemic Sclerosis",
          "Scleroderma",
          "stem cell treatment"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Treatment Group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Single intravenous infusion of 100 million cells",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: AlloRx"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "AlloRx",
            "InterventionDescription": "cultured allogeneic adult umbilical cord derived mesenchymal stem cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Treatment Group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Safety (adverse events)",
            "PrimaryOutcomeDescription": "Clinical monitoring of possible adverse events or complications",
            "PrimaryOutcomeTimeFrame": "Four year follow-up"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Efficacy: skin score",
            "SecondaryOutcomeDescription": "It will be completed for each follow up point.",
            "SecondaryOutcomeTimeFrame": "Four year follow-up"
          },
          {
            "SecondaryOutcomeMeasure": "Efficacy: Forced vital capacity (FVC)",
            "SecondaryOutcomeDescription": "It will be completed for each follow up point.",
            "SecondaryOutcomeTimeFrame": "Four year follow-up"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of Systemic Sclerosis\nUnderstanding and willingness to sign a written informed consent document\n\nExclusion Criteria:\n\nActive infection\nActive cancer\nChronic multisystem organ failure\nPregnancy\nClinically significant Abnormalities on pre-treatment laboratory evaluation\nMedical condition that would (based on the opinion of the investigator) compromise patient's safety.\nContinued drug abuse\nPre-menopausal women not using contraception\nPrevious organ transplant\nHypersensitivity to sulfur",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Chadwick Prodromos, MD",
            "OverallOfficialAffiliation": "The Foundation for Orthopaedics and Regenerative Medicine",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Medical Surgical Associates Center",
            "LocationStatus": "Recruiting",
            "LocationCity": "St. John's",
            "LocationCountry": "Antigua and Barbuda",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Chadwick Prodromos, M.D.",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "8476996810",
                  "LocationContactEMail": "care@thepsci.com"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "19605370",
            "ReferenceType": "background",
            "ReferenceCitation": "Kaldas M, Khanna PP, Furst DE, Clements PJ, Kee Wong W, Seibold JR, Postlethwaite AE, Khanna D; investigators of the human recombinant relaxin and oral bovine collagen clinical trials. Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials. Rheumatology (Oxford). 2009 Sep;48(9):1143-6. doi: 10.1093/rheumatology/kep202. Epub 2009 Jul 14."
          },
          {
            "ReferencePMID": "25114060",
            "ReferenceType": "background",
            "ReferenceCitation": "Granel B, Daumas A, Jouve E, Harl√© JR, Nguyen PS, Chabannon C, Colavolpe N, Reynier JC, Truillet R, Mallet S, Baiada A, Casanova D, Giraudo L, Arnaud L, Veran J, Sabatier F, Magalon G. Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis. 2015 Dec;74(12):2175-82. doi: 10.1136/annrheumdis-2014-205681. Epub 2014 Aug 11."
          },
          {
            "ReferencePMID": "30616671",
            "ReferenceType": "background",
            "ReferenceCitation": "Del Papa N, Di Luca G, Andracco R, Zaccara E, Maglione W, Pignataro F, Minniti A, Vitali C. Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study. Arthritis Res Ther. 2019 Jan 7;21(1):7. doi: 10.1186/s13075-018-1792-8."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000012595",
            "ConditionMeshTerm": "Scleroderma, Systemic"
          },
          {
            "ConditionMeshId": "D000045743",
            "ConditionMeshTerm": "Scleroderma, Diffuse"
          },
          {
            "ConditionMeshId": "D000012598",
            "ConditionMeshTerm": "Sclerosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000003240",
            "ConditionAncestorTerm": "Connective Tissue Diseases"
          },
          {
            "ConditionAncestorId": "D000012871",
            "ConditionAncestorTerm": "Skin Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M14567",
            "ConditionBrowseLeafName": "Sclerosis",
            "ConditionBrowseLeafAsFound": "Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14564",
            "ConditionBrowseLeafName": "Scleroderma, Systemic",
            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M24713",
            "ConditionBrowseLeafName": "Scleroderma, Diffuse",
            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M5616",
            "ConditionBrowseLeafName": "Connective Tissue Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14826",
            "ConditionBrowseLeafName": "Skin Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T5565",
            "ConditionBrowseLeafName": "Systemic Scleroderma",
            "ConditionBrowseLeafAsFound": "Systemic Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}